Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 12832

Original article / research
Year : 2017 | Month : October | Volume : 11 | Issue : 10 | Page : XC01 - XC05

Comparison of Toxicities Associated with Concomitant Boost and Conventional Fractionated Radiotherapy Regimen in Oral and Oropharyngeal Cancers

Abhishek Shrivastava, Hameeduzzafar Ghori, Omprakash Singh, Vivek Ti Wari, Veenita Yogi, Ramsingh Jamre, Varsha Mandloi

1. Postgraduate Student, Department of Radiation Oncology, Gandhi Medical College, Bhopal, Madhya Pradesh, India. 2. Associate Professor, Department of Radiation Oncology, Gandhi Medical College, Bhopal, Madhya Pradesh, India. 3. Professor and Head, Department of Radiation Oncology, Gandhi Medical College, Bhopal, Madhya Pradesh, India. 4. Assistant Professor, Department of Radiation Oncology, Gandhi Medical College, Bhopal, Madhya Pradesh, India. 5. Assistant Professor, Department of Radiation Oncology, Gandhi Medical College, Bhopal, Madhya Pradesh, India. 6. Postgraduate Student, Department of Radiation Oncology, Gandhi Medical College, Bhopal, Madhya Pradesh, India. 7. Postgraduate Student, Department of Radiation Oncology, Gandhi Medical College, Bhopal, Madhya Pradesh, India.

Correspondence Address :
Dr. Vivek Tiwari,
B-79, Rajved Colony, Nayapura, Kolar Road, Bhopal-462042, Madhya Pradesh, India.
E-mail: dr_vivektiwari@rediffmail.com

Abstract

Introduction: The prevalence of Head and Neck Cancers (HNC) is very high in the Indian subcontinent. Radiotherapy is an essential modality in the management of HNC.

Aim: The aim of the present study was to compare toxicities of two radiotherapy fractionation regimen (conventional fractionation and concomitant boost technique) for the management of HNC.

Materials and Methods: A total of 60 patients (n=30 in each arm) were assigned to receive either conventional fractionation or concomitant boost radiotherapy. Toxicities were analysed weekly during the treatment, and one and three month after treatment completion. The radiation therapy oncology group acute radiation morbidity scoring system was used to document the severity. Toxicities assessed were mucositis, skin reactions, dysphagia and xerostomia. Statistical analysis was done by the online graph pad software using Chi-square test. A value of p<0.05 was considered significant.

Results: Overall mean age of the patients was 47.35 years (range 23-70 years). There was a male preponderance in both groups (Group A=73.33%, Group B= 76.6%). Most common primary sub site in Group A was tongue (33.3%) and in Group B was buccal mucosa (50%). On statistical analysis of toxicity comparison during and post treatment completion, no significant difference in toxicity was found between the two arms in terms of mucositis (p=1), skin reactions (p=0.6404), dysphagia (p=0.7906) and xerostomia (p=0.1066).

Conclusion: The concomitant boost technique resulted in no statistically significant difference in toxicity as compared to the conventional fractionation with the added advantage of reduced overall treatment time. This may be a favourable schedule for high volume centers.

Keywords

Fractionation, Head and Neck cancers, Morbidity, Radiotherapy

How to cite this article :

Abhishek Shrivastava, Hameeduzzafar Ghori, Omprakash Singh, Vivek Ti Wari, Veenita Yogi, Ramsingh Jamre, et al.. COMPARISON OF TOXICITIES ASSOCIATED WITH CONCOMITANT BOOST AND CONVENTIONAL FRACTIONATED RADIOTHERAPY REGIMEN IN ORAL AND OROPHARYNGEAL CANCERS. Journal of Clinical and Diagnostic Research [serial online] 2017 October [cited: 2017 Oct 23 ]; 11:XC01-XC05. Available from
http://www.jcdr.net/back_issues.asp?issn=0973-709x&year=2017&month=October&volume=11&issue=10&page=XC01-XC05&id=10692

DOI and Others

DOI: 10.7860/JCDR/2017/30115.10692

Date of Submission: May 13, 2017
Date of Peer Review: Jun 26, 2017
Date of Acceptance: Sep 06, 2017
Date of Publishing: Oct 01, 2017

FINANCIAL OR OTHER COMPETING INTERESTS: None.

JCDR is now Monthly and more widely Indexed .
  • PubMed Central® (PMC)New
  • Academic Search Complete Database
  • Chemical Abstracts Service
  • Directory of Open Access Journals (DOAJ)
  • EBSCOhostNew
  • Embase & EMbiology
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Open J-Gate
  • Popline (reproductive health literature)
  • SCOPUS
  • www.omnimedicalsearch.com